💥How to Win Family Office LPs, Why LPs Need VC Exposure, More Shots Needed at Seed, Incumbent Squeeze & More
1. Key Themes
LPs are structurally underweight venture despite AI-driven outperformance
Jen Kha's a16z analysis shows LPs still allocate to venture as if it were a minor satellite strategy, even though a handful of AI companies now represent trillions in value.
"they regularly meet LPs holding close to zero exposure to SpaceX, Anthropic, and OpenAI, some $3.8-5T of combined value built largely in private markets, while venture sits at just 5-10% of a typical portfolio."
The comparison to PE is stark, given how concentrated venture outcomes have become.
"SpaceX's roughly $2.1T debut came in around 39 times the largest PE-backed IPO on record, Medline at $54B."
Access, not allocation size, is what actually matters for LPs trying to capture these returns.
"Accolade Partners' Aram Verdiyan puts it at 20 of roughly 3,000 US firms compounding at 3x net over two decades."
Venture capital is bifurcating into "concentrated bets" vs. overlooked categories, killing the middle
Ethan Kurzweil (Chemistry) argues capital is polarizing toward mega-bets on consensus AI while non-consensus sectors get starved of capital.
"Kurzweil cites Peter Walker's Carta data on venture moving toward higher valuations in a shrinking set of companies, what Walker calls 'concentrated bets as an asset class.'"
This creates a real strategic choice for both investors and founders — there's no safe middle path.
"pay a premium for the rare founder capable of a trillion-dollar outcome, or build conviction in overlooked categories before pricing catches up. Staying in the middle risks being squeezed from both sides as capital keeps polarizing."
Seed funds must fundamentally rethink portfolio construction as Series A graduation rates collapse
Gil Dibner (Angular Ventures) shows the math behind seed investing has shifted meaningfully since 2021.
"a seed fund expecting a 50% graduation rate at 24 investments should now plan for closer to 10-25% at 40, using volume to offset falling odds."
The bar for graduating has risen even as odds of clearing it have fallen.
"Seed-to-Series A graduation rates have declined since 2021 even as the qualifying bar keeps rising across metrics like ARR, growth rate, and NRR."
Incumbents are moving up the "agent judgment ladder," threatening vertical AI startups' moats
Seema Amble (a16z) maps how established software players are evolving from passive record-keepers into active agents.
"Docusign's Iris reviews contracts, Atlassian's Rovo routes requests, and Klaviyo's Composer builds campaigns, each pushing past chatbots into agents that act."
The real defensibility question is whether startups can capture reasoning, not just outcomes.
"Finished records show outcomes without the reasoning behind them... Startups that capture that reasoning keep getting better at the job."
AI's realized ROI inside VC firms is concentrated in front-office, high-velocity functions
The DDVC Landscape Report data shows a steep drop-off from sourcing to relationship-driven work.
"deal sourcing and screening leads at 50%, followed by internal workflows and automation at 35% and due diligence and research at 32%" "Outreach and communications, LP and IR, and legal and compliance all cluster at 10-11%, the functions closest to actual human relationships showing the least AI impact so far."
2. Contrarian Perspectives
- The "safe" side of the alternatives portfolio (buyout/PE) may be riskier than perceived, not safer. Kha's argument inverts conventional LP wisdom that PE is the stable core while venture is the risky satellite.
"The piece links AI's disruption of recurring revenue to buyout returns now near 15-year lows, arguing the conservative side of the alternatives book carries real risk of its own."
- Reflexive follow-on reserves at seed are a bad bet, not a prudent one. Dibner challenges standard portfolio construction orthodoxy that preserving dry powder for winners is always correct.
"Dibner argues seed funds should ruthlessly cut reserves for reflexive follow-ons, treating every follow-on dollar as competing against the option of one more initial check."
- Data access alone is not a defensible moat for vertical AI startups, since general-purpose agents can already reach into incumbent systems.
"Data access alone won't be the moat once general agents like Claude can already reach across systems."
3. Companies Identified
- SpaceX, Anthropic, OpenAI — AI/space private companies; cited as evidence LPs are missing massive private-market value creation.
"some $3.8-5T of combined value built largely in private markets, while venture sits at just 5-10% of a typical portfolio."
- Medline — PE-backed healthcare company; used as a benchmark to show how much larger VC-backed exits have become.
"SpaceX's roughly $2.1T debut came in around 39 times the largest PE-backed IPO on record, Medline at $54B."
- Chemistry (VC firm) — Venture firm explicitly straddling both consensus and non-consensus bets.
"The firm backs pricey consensus AI founders alongside others building in sectors far from the heat, and expects both camps to produce real winners and expensive disappointments."
- Docusign (Iris), Atlassian (Rovo), Klaviyo (Composer), Salesforce (Claudeforce) — Incumbent software companies building AI agents; cited as case studies of incumbents moving from passive tools to active agents.
"Docusign's Iris reviews contracts, Atlassian's Rovo routes requests, and Klaviyo's Composer builds campaigns... Salesforce's Claudeforce takes a different route, putting Claude in front of CRM data Salesforce still owns."
- Standard Metrics — AI-driven portfolio management/data platform for VC firms; newsletter sponsor showcased as an operating tool.
"Standard Metrics builds that foundation for 150+ investment firms... Cut portfolio reporting time by 90%."
4. People Identified
- Jen Kha — a16z, author of the LP allocation piece; noted for framing venture's outsized private-market impact relative to LP exposure.
"makes the case that LP portfolios are still sized for a decades-old, small-allocation approach to venture."
- Aram Verdiyan — Accolade Partners; cited for quantifying access concentration in top VC funds.
"20 of roughly 3,000 US firms compounding at 3x net over two decades."
- Ethan Kurzweil — Chemistry, author of the "vanishing middle ground" thesis; notable for describing his own firm's dual-camp strategy.
"argues that venture has split into two extremes with no viable middle ground."
- Peter Walker — Carta; cited for data showing capital concentration into fewer, higher-valued companies.
"Peter Walker's Carta data on venture moving toward higher valuations in a shrinking set of companies, what Walker calls 'concentrated bets as an asset class.'"
- Gil Dibner — Angular Ventures, author of the seed portfolio construction analysis; notable for reworking graduation-rate math for seed funds.
"breaks down how inception-stage portfolio construction needs to change... as Series A graduation rates keep falling."
- Seema Amble — a16z, author of the vertical AI vs. incumbents mapping; notable for the "agent judgment ladder" framework.
"maps out where AI incumbents and vertical AI-native startups will actually compete as agent capabilities move up the judgment ladder."
5. Operating Insights
- For seed GPs: Increase the number of initial checks and raise the bar dramatically for follow-on capital, since graduation odds have fallen faster than most models assume.
"as graduation odds keep falling, funds need more initial checks and a much higher bar for every follow-on dollar."
- For vertical AI investors/founders: Diligence should focus on whether a startup can build a "learning loop" from captured reasoning (not just outcomes), and whether it can expand from a single task into an entire job function — this is the real moat versus incumbents.
"can experts judge the work, is judgment genuinely required, does it happen often enough to build a learning loop, and can the startup expand from one assignment into the full job."
- For emerging GPs pitching family offices: Pre-empt the track record objection by separating personal judgment wins from firm-infrastructure-dependent wins, and read the family's generational stage (G1/G2/G3) before pitching, as it predicts receptivity.
"Could they hand you their money, sail away for three years, and trust it was cared for? Why pick you over a16z or Sequoia? And what do you believe about the future that most investors don't?"
6. Overlooked Insights
- Firm-level AI adoption gap as a potential competitive edge: While sourcing/screening AI use is now table stakes (50% adoption), outreach, LP/IR, and legal remain almost untouched (10-11%) — suggesting a differentiation opportunity for GPs willing to apply AI to relationship-heavy functions without losing the human touch.
"outreach and LP relationships look like an open gap a firm could turn into an edge without losing the human touch."
- Family office size is a non-obvious predictor of investment behavior — it's not linear; both very small and very large family offices behave more like conservative endowments, while mid-sized ones are the most entrepreneurial and fast-moving targets for emerging GPs.
"Small (under $500M AUM) and large (over $2B AUM) family offices run closer to a fixed-bucket endowment model; mid-sized offices in between are more entrepreneurial and faster to invest directly."